Progressive supranuclear palsy in a sample of Brazilian population: Clinical features of 16 patients

Arquivos de Neuro-Psiquiatria

Volumn 60, Issue 4, 2002, Pages 917-922

  Carrilho, Paulo Eduardo Mestrinelli ^a,c   Barbosa, Egberto Reis ^b  

^a UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Chronic dacryocystitis; Movement disorders; Parkinsonism; Progressive supranuclear palsy

Indexed keywords

ADULT; AGED; ARTICLE; BODY POSTURE; BRAZIL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DACRYOCYSTITIS; DEGENERATIVE DISEASE; DIAGNOSTIC VALUE; FALLING; FEMALE; GAZE PARALYSIS; HUMAN; MALE; ONSET AGE; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY; TREMOR; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; AGED, 80 AND OVER; BRAZIL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0036897981     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2002000600006     Document Type: Article

References (23)

1. Richardson JC, Steele J, Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of heterogeneous system degeneration. Trans Am Neurol Ass 1963;88:25-29.
2. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-358.
3. Colosimo C, Albanese A, Hughes AJ, De Bruin VM, Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995;52:294-298.
4. De Bruin VM, Lees AJ. Subcortical neurofibrillary degeneration presenting as SRO and other related syndromes: A review of 90 pathologically verified cases. Mov Disord 1994;9:381-389.
5. Fénelon G, Guillard A, Romatet S, Feve A, Mahieux F. Les signes parkinsoniens du syndrome de Steele-Richardson-Olszewski. Rev Neurol (Paris) 1993;149:30-36.
6. Golbe LI, Davis PH. Progressive supranuclear palsy. In Jankovic J, Tolosa E (Eds.). Parkinson's disease and movement disorders. Baltimore, Williams & Wilkins, 1993:145-161.
7. Kristensen MO. Progressive supranuclear palsy: 20 Years later. Acta Neurol Scand 1985;71:177.
8. Litvan I. The clinical and pathological hallmarks of progressive supranuclear palsy. Cur Opin Neurol 1997;10:346-350.
9. Litvan I, Mangone CA, Mckee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical prediction of survival: A clinicopathological study. J Neurol Neurosurg Psychiatry 1996;60:615-620.
10. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
11. Maher ER, Lees AJ. The clinical features and natural hystory of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986;36:1005-1008.
12. Steele JC. Progressive supranuclear palsy. Brain 1972;95:693-704.
13. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism: A prospective study. Can J Neurol Sci 1991;18:275-278.
14. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996;46:922-930.
15. Litvan I. Progressive supranuclear palsy: Staring into the past, moving into the future. Neurologist 1998;4:13-20.
16. Folstein MF, Folstein SE, Mchugh PR. "Mini-mental state": A clinical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Collins SJ, Ahlskog JE, Parisi JE, Maranganore DM. Progressive supranuclear palsy: Neuropathologically based diagnostic criteria. J Neurol Neurosurg Psychiatry 1995;58:167-173.
18. Jackson JA, Jankovic J, Ford J. Progressive supranuclear palsy: Clinical features and response to tratment in 16 patients. Ann Neurol 1983;13:273-278.
19. Albert MI, Feldman RG, Willis AL. The "subcortical dementia" of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974;17:121-130.
20. Daniel SE, De Bruin VM, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (PSP): A reappraisal. Brain 1995;118:759-770.
21. Vermesch P, Robitaille Y, Bernier L. Biochemical mapping of neurofibrillary degeneration in a case of psp: Evidence for general cortical involvement. Acta Neuropathol (Berlin) 1994;87:572-577.
22. Verny M, Duyckaert S, Agid Y, Hauw JJ. The significance of cortical pathology in progressive supranuclear palsy: Clinico-pathological data in 10 cases. Brain 1996;119:1123-1136.
23. Foster N, Sima AAF, D'Amato C, et al. Cerebral cortical pathology in progressive supranuclear palsy is correlated with severity of dementia. Neurology 1996;46:A363.